With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
NTES trades against a final fair-value range of $139.31-$218.83, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A bear-case stress test assuming a 500bps margin compression and 0% terminal growthTerminal growthThe perpetual growth rate assumed in the Gordon-growth terminal-value calculation. Capped below long-run nominal GDP (typically 2.5–3.0% for developed-market firms). resets fair valueFair valueOur composite estimate of intrinsic per-share value, blended across DCF, exit-multiple, and reverse-DCF methods. Reported as a low/mid/high range to capture model uncertainty. to $139.31. Even in this high-pessimism scenario, the massive net cash position ($40B+) provides a structural floor representing 55% of the current market capitalization.
China introduces draconian caps on daily spending and loot box mechanics for legacy titles.
High-budget international launches (Where Winds Meet) fail to gain traction, rendering global R&D sunk costs.
Geopolitical escalation leads to restrictions on offshore cash transfers or ADR de-listing.
| Line item | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|
| Revenue | $96.50B | $103.47B+7.2% | $105.30B+1.8% | $112.63B+7.0% | +5.3% |
| Gross profit | $52.77B | $63.06B | $65.81B | $72.40B | +11.1% |
| Operating income | $19.63B | $27.71B | $29.58B | $35.83B | +22.2% |
| Net income | $20.34B | $29.42B+44.6% | $29.70B+1.0% | $33.76B+13.7% | +18.4% |
| EPS (diluted) | $30.85 | $45.25 | $45.95 | $52.40 | +19.3% |
| EBITDA | $22.49B | $30.76B | $32.00B | $38.08B | +19.2% |
| R&D | $15.04B | $16.48B | $17.52B | $17.72B | +5.6% |
| SG&A | $18.10B | $18.87B | $18.70B | $18.85B | +1.4% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Operating margin compression below 28% threshold | Monitor | Deterioration versus the report thesis |
| Resumption of aggressive regulatory fines | Monitor | Deterioration versus the report thesis |
